Prospective external validation of biomarkers to predict acute graft-versus-host disease severity

Key Points Biomarker panels at GVHD onset, independently from clinical parameters, were associated with survival and nonrelapse mortality. Using 3 different biostatistical tools, biomarkers only slightly improved prediction over clinical parameters.